Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
作者信息
Pultz Michael J, Donskey Curtis J
出版信息
Antimicrob Agents Chemother. 2007 Aug;51(8):3044-5. doi: 10.1128/AAC.00194-07. Epub 2007 Jun 11.
Abstract
摘要
相似文献
1
Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.亚胺培南-西司他丁、厄他培南、哌拉西林-他唑巴坦及头孢曲松治疗对产超广谱β-内酰胺酶肺炎克雷伯菌菌株在小鼠肠道定植持续性的影响
Antimicrob Agents Chemother. 2007 Aug;51(8):3044-5. doi: 10.1128/AAC.00194-07. Epub 2007 Jun 11.
2
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.哌拉西林/他唑巴坦治疗新生儿肺炎克雷伯菌感染
Am J Perinatol. 1998 Jan;15(1):47-51. doi: 10.1055/s-2007-993898.
3
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.广谱β-内酰胺类抗生素治疗产碳青霉烯酶 OXA-48 的肺炎克雷伯菌所致实验性腹膜炎的小鼠。
Antimicrob Agents Chemother. 2012 May;56(5):2759-60. doi: 10.1128/AAC.06069-11. Epub 2012 Feb 13.
4
Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice.碳青霉烯类药物给药对小鼠体内耐万古霉素肠球菌和肺炎克雷伯菌肠道定植的影响。
Antimicrob Agents Chemother. 2007 Jan;51(1):372-5. doi: 10.1128/AAC.00355-06. Epub 2006 Oct 16.
5
Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.亚胺培南-西司他丁、美罗培南和哌拉西林-他唑巴坦用于皮肤和软组织感染经验性治疗的药效学建模：OPTAMA项目报告
Surg Infect (Larchmt). 2005 Winter;6(4):419-26. doi: 10.1089/sur.2005.6.419.
6
Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection.哌拉西林/他唑巴坦与亚胺培南/西司他丁治疗腹腔内感染患者的随机对照比较
Asian J Surg. 2004 Jul;27(3):227-35. doi: 10.1016/S1015-9584(09)60039-7.
7
In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.产超广谱β-内酰胺酶肺炎克雷伯菌不同接种量时哌拉西林-他唑巴坦和美罗培南的体外和体内活性。
Clin Microbiol Infect. 2014 Nov;20(11):O831-9. doi: 10.1111/1469-0691.12677. Epub 2014 Jun 14.
8
Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.产超广谱β-内酰胺酶肠杆菌科细菌对厄他培南、美罗培南以及含与不含克拉维酸的哌拉西林-他唑巴坦的敏感性。
Chemotherapy. 2007;53(3):185-9. doi: 10.1159/000100516. Epub 2007 Mar 7.
9
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.产超广谱β-内酰胺酶肺炎克雷伯菌引起的心内膜炎：尽管初始时敏感，但治疗期间对环丙沙星和哌拉西林-他唑巴坦出现耐药。
Antimicrob Agents Chemother. 2006 Sep;50(9):3179-82. doi: 10.1128/AAC.00218-06.
10
Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.希腊一家三级护理医院实施限制政策后，肺炎克雷伯菌和大肠埃希菌临床分离株对第三代和第四代头孢菌素以及哌拉西林/他唑巴坦耐药模式变化的差异。
Int J Antimicrob Agents. 2007 Jan;29(1):34-8. doi: 10.1016/j.ijantimicag.2006.08.042.
引用本文的文献
1
Effect of Ceftaroline, Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam on Establishment of Colonization by Vancomycin-Resistant Enterococci and in Mice.头孢洛林、头孢他啶/阿维巴坦、头孢托罗/他唑巴坦和美罗培南/瓦博巴坦对耐万古霉素肠球菌在小鼠体内定殖的影响
Pathog Immun. 2024 Sep 24;9(2):194-204. doi: 10.20411/pai.v9i2.711. eCollection 2024.
2
The impact of three carbapenems at a single-day dose on intestinal colonization resistance against carbapenem-resistant .三种碳青霉烯类药物在单日内剂量对耐碳青霉烯肠定植耐药性的影响。
mSphere. 2023 Dec 20;8(6):e0047923. doi: 10.1128/msphere.00479-23. Epub 2023 Nov 27.
3
Antimicrobial Stewardship Program: Reducing Antibiotic's Spectrum of Activity Is not the Solution to Limit the Emergence of Multidrug-Resistant Bacteria.抗菌药物管理计划：缩小抗生素的抗菌谱并非限制多重耐药菌出现的解决办法。
Antibiotics (Basel). 2022 Jan 7;11(1):70. doi: 10.3390/antibiotics11010070.
4
A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment.一种用于研究在使用头孢噻肟和头孢曲松等复合抗生素治疗期间肠道细菌参数的小鼠模型。
Comput Struct Biotechnol J. 2021 Mar 4;19:1423-1430. doi: 10.1016/j.csbj.2021.02.019. eCollection 2021.
5
Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum β-lactamase producing Escherichia coli in a mouse model.头孢曲松和替莫西林对小鼠模型中产超广谱β-内酰胺酶大肠杆菌粪便丰度的影响。
PLoS One. 2021 Mar 10;16(3):e0248177. doi: 10.1371/journal.pone.0248177. eCollection 2021.
6
Piperacillin-tazobactam as alternative to carbapenems for ICU patients.哌拉西林-他唑巴坦作为重症监护病房患者碳青霉烯类药物的替代用药
Ann Intensive Care. 2017 Nov 10;7(1):113. doi: 10.1186/s13613-017-0334-x.
7
Severe sepsis facilitates intestinal colonization by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and transfer of the SHV-18 resistance gene to Escherichia coli during antimicrobial treatment.严重脓毒症在抗菌治疗期间促进产超广谱β-内酰胺酶肺炎克雷伯菌的肠道定植和 SHV-18 耐药基因向大肠埃希菌的转移。
Antimicrob Agents Chemother. 2014;58(2):1039-46. doi: 10.1128/AAC.01632-13. Epub 2013 Nov 25.
8
Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.抗生素治疗对产 KPC 肺炎克雷伯菌在小鼠肠道定植和消除的影响。
Antimicrob Agents Chemother. 2011 Jun;55(6):2585-9. doi: 10.1128/AAC.00891-10. Epub 2011 Mar 21.
本文引用的文献
1
Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice.碳青霉烯类药物给药对小鼠体内耐万古霉素肠球菌和肺炎克雷伯菌肠道定植的影响。
Antimicrob Agents Chemother. 2007 Jan;51(1):372-5. doi: 10.1128/AAC.00355-06. Epub 2006 Oct 16.
2
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.腹腔内感染抗菌治疗后耐药革兰氏阴性杆菌的肠道定植：厄他培南治疗两项随机对照临床试验的观察结果
Eur J Clin Microbiol Infect Dis. 2005 Jul;24(7):443-9. doi: 10.1007/s10096-005-1356-0.
3
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.在男性和女性志愿者多次给药后，与头孢曲松相比，厄他培南的药代动力学及其对肠道微生物群的影响。
Antimicrob Agents Chemother. 2004 Oct;48(10):3765-72. doi: 10.1128/AAC.48.10.3765-3772.2004.
4
The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens.肠道作为医院感染病原体储存库和传播源的作用。
Clin Infect Dis. 2004 Jul 15;39(2):219-26. doi: 10.1086/422002. Epub 2004 Jun 25.
5
Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.肠道外给予抗生素对产超广谱β-内酰胺酶的肺炎克雷伯菌菌株在小鼠肠道定植的影响。
Antimicrob Agents Chemother. 2003 Nov;47(11):3610-2. doi: 10.1128/AAC.47.11.3610-3612.2003.
6
Effect of antimicrobial agents on the ecological balance of human microflora.抗菌药物对人体微生物群落生态平衡的影响。
Lancet Infect Dis. 2001 Sep;1(2):101-14. doi: 10.1016/S1473-3099(01)00066-4.
7
Effect of imipenem/cilastatin on the colonic microflora.亚胺培南/西司他丁对结肠微生物群的影响。
Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S432-4. doi: 10.1093/clinids/7.supplement_3.s432.
8
Impact of imipenem/cilastatin therapy on normal fecal flora.亚胺培南/西司他丁疗法对正常粪便菌群的影响。
Am J Med. 1985 Jun 7;78(6A):41-6. doi: 10.1016/0002-9343(85)90100-7.
Zotero 插件